CARSGEN-B (02171) saw its shares rally nearly 5% in Thursday morning trade following the release of its interim results. The stock was up 4.63% at HK$15.38 at the time of writing, with turnover reaching HK$23.89 million.

On August 18, the company reported its 2026 interim results, posting revenue of approximately RMB 61.9 million, a year-on-year increase of 21.5%. The adjusted net loss narrowed by 55.53% to RMB 31.93 million, while the loss attributable to owners of the parent company contracted by 11.52% to RMB 66.66 million. The loss per share stood at RMB 0.13.

According to the company's announcement, the revenue growth was primarily driven by higher sales volumes of Saikeze (a product name). The reduction in adjusted net loss was mainly attributed to a decrease in administrative expenses.